Overview of the ESMO Guidelines Real World Webinar
The Oncology community closely follows the European Society for Medical Oncology (ESMO) guidelines, which set the standard for evidence-based care in cervical cancer. The upcoming virtual session, ESMO Guidelines Cervical Cancer 2026: Real World Webinar, brings together leaders in gynecologic oncology to discuss how the 2026 guidelines translate into everyday clinical decisions. Scheduled for June 24, 2026, and chaired by renowned expert Ana Oaknin, the event is designed to help oncology professionals bridge the gap between guideline recommendations and real-world patient care.
What to Expect: Goals and Format
The webinar series focuses on real-world cases that clinicians encounter, highlighting practical strategies for treatment selection, sequencing, and management of side effects. Attendees will gain insights into how updated recommendations—from adjuvant therapy to systemic regimens and supportive care—can be applied across diverse patient populations. The format features expert-led discussions, case-based scenarios, and opportunities for interactive questions, making complex guidelines more accessible to busy oncology teams.
Key Topics for Cervical Cancer in 2026
While the exact program may evolve, the session is expected to cover core areas of contemporary cervical cancer care:
- Risk stratification and stage-adapted therapy in line with the 2026 guidelines
- Role of chemoradiation, targeted therapy, and immunotherapy across stages
- Management of recurrent or metastatic disease, including registry data and real-world outcomes
- Toxicity management, quality of life, and survivorship considerations
- Health-system implementation: how centers of varying resources can apply guidelines effectively
Translating Evidence to Practice
A central aim is helping clinicians interpret trial data in the context of real-world constraints—comorbidities, access to therapies, and patient preferences. The discussion will emphasize patient-centric decision-making, shared decision processes, and practical checklists that can be used during tumor boards and clinic visits.
Chair and Speakers: Driving Meaningful Conversations
Ana Oaknin will guide the discussions, drawing on her extensive experience in gynecologic oncology and her work with ESMO guidelines. The webinar will also feature oncologists and researchers who bring frontline clinical insight, enabling attendees to hear diverse perspectives on the applicability of guidelines to routine practice.
Who Should Attend and Why It Matters
The session is designed for radiation oncologists, medical oncologists, gynecologic surgeons, pathologists, radiologists, nurse navigators, and allied health professionals involved in cervical cancer care. By focusing on real-world scenarios, the webinar helps multidisciplinary teams align on evidence-based approaches that remain feasible and patient-centered across different healthcare settings.
Logistics and How to Participate
As a virtual scientific session, the event removes travel barriers while maintaining the depth of in-person conferences. Attendees should register in advance to access the live program, participate in Q&A segments, and obtain continuing medical education credits where applicable. The session is part of an ongoing commitment by ESMO to translate complex guideline updates into practical, real-world actions that improve patient outcomes.
Takeaways for Everyday Practice
After the session, clinicians should be able to: integrate the 2026 guideline recommendations into treatment pathways; apply case-based learnings to their patient cohorts; and enhance multidisciplinary collaboration to optimize cervical cancer management. The real-world focus of this webinar aims to accelerate the adoption of best practices and improve care delivery for patients worldwide.
